Public Joint-Stock Company "Pharmsynthez" (LIFE.ME)

RUB 4.22

(1.2%)

Long Term Debt Summary of Public Joint-Stock Company "Pharmsynthez"

  • Public Joint-Stock Company "Pharmsynthez"'s latest annual long term debt in 2022 was 41.77 Million RUB , down -51.9% from previous year.
  • Public Joint-Stock Company "Pharmsynthez"'s latest quarterly long term debt in 2023 Q1 was 40.77 Million RUB , down -2.4% from previous quarter.
  • Public Joint-Stock Company "Pharmsynthez" reported annual long term debt of 86.84 Million RUB in 2021, up 558.0% from previous year.
  • Public Joint-Stock Company "Pharmsynthez" reported annual long term debt of 13.19 Million RUB in 2020, down -91.94% from previous year.
  • Public Joint-Stock Company "Pharmsynthez" reported quarterly long term debt of 40.77 Million RUB for 2023 Q2, down 0.0% from previous quarter.
  • Public Joint-Stock Company "Pharmsynthez" reported quarterly long term debt of 56.46 Million RUB for 2022 Q2, down 0.0% from previous quarter.

Annual Long Term Debt Chart of Public Joint-Stock Company "Pharmsynthez" (2022 - 2007)

Historical Annual Long Term Debt of Public Joint-Stock Company "Pharmsynthez" (2022 - 2007)

Year Long Term Debt Long Term Debt Growth
2022 41.77 Million RUB -51.9%
2021 86.84 Million RUB 558.0%
2020 13.19 Million RUB -91.94%
2019 163.7 Million RUB 174.3%
2018 59.68 Million RUB 11.37%
2017 53.58 Million RUB 0.0%
2016 - RUB -100.0%
2015 2.23 Million RUB -60.14%
2014 5.59 Million RUB 45.32%
2013 3.85 Million RUB 131.0%
2012 1.66 Million RUB 0.0%
2011 - RUB 0.0%
2010 - RUB 0.0%
2009 - RUB 0.0%
2008 - RUB 0.0%
2007 - RUB 0.0%

Peer Long Term Debt Comparison of Public Joint-Stock Company "Pharmsynthez"

Name Long Term Debt Long Term Debt Difference